Mutation

(redirected from Mutations)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

MUTATION, French law. This term is synonymous with change, and is particularly applied to designate the change which takes place in the property of a thing in its transmission from one person to another; permutation therefore happens when, the owner of the thing sells, exchanges or gives it. It is nearly synonymous with transfer. (q.v.) Merl. Repert. h.t.

References in periodicals archive ?
Isolates were tested for drug susceptibility and resistant isolates were investigated for mutations analysis in the 'hot spot regions' of rpoB, rpsL, embB, pncA, gyrA and gyrB genes.
2) In recent years, additional genetic factors such as the mutations of IDH1/2, TET2, EZH2, ASXL1, and CALR have been identified in Ph-negative MPNs.
Amongst others, mutations in GPR54 and GnRH receptor (GNRHR) are possible causes of HH.
Background: Dysferlinopathy is caused by mutations in the dysferlin (DYSF) gene.
This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer (NSCLC).
April 14, 2016 -- Scientists here have confirmed the longstanding hypothesis that as people age, they accumulate gene mutations in their mitochondria, the cell's energy source.
Microbes can reveal which mutations colon cancers carry.
M2 PHARMA-September 4, 2014-Myriad Genetics' myRisk Hereditary Cancer test improves by 46% detection of cancer-causing mutations
Washington, August 26 ( ANI ): A group of researchers have made a significant breakthrough for figuring out which mutations are benign and which are deleterious in cystic fibrosis.
Recently MPL mutations (MPL W515L or MPL W515K) were described in patients with essential thrombocythemia (ET) and primary (idiopathic) myelofibrosis (PMF).
Analysis for known and novel mutations in these areas of the gene was performed first by unidirectional sequencing followed by confirmation of all observed potential sequence changes in the opposite direction.
Researchers have discovered that women who do not have a BRCA1 or BRCA2 gene mutation but have a female first-degree relative (mother, sister, or daughter) with a BRCA mutation do not have an increased risk of breast cancer compared to women with no personal or familial mutations.